Status: current, Defined. Date: 30-Nov 2016. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1721651000168116 | amylase 3600 BP units / 100 mg + lipase 5000 BP units / 100 mg + protease 200 Ph Eur units / 100 mg enteric coated granules (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 1721661000168119 | lipase 5000 units/100 mg + amylase 3600 units/100 mg + protease 200 units/100 mg enteric coated granules | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| lipase 5000 units/100 mg + amylase 3600 units/100 mg + protease 200 units/100 mg enteric coated granules | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| lipase 5000 units/100 mg + amylase 3600 units/100 mg + protease 200 units/100 mg enteric coated granules | Is a | lipase + amylase + protease | true | Inferred relationship | Some | ||
| lipase 5000 units/100 mg + amylase 3600 units/100 mg + protease 200 units/100 mg enteric coated granules | has manufactured dose form | enteric coated granules dose form (AU qualifier) | true | Inferred relationship | Some | ||
| lipase 5000 units/100 mg + amylase 3600 units/100 mg + protease 200 units/100 mg enteric coated granules | has unit of use | continuous | true | Inferred relationship | Some | 1954298725 | |
| lipase 5000 units/100 mg + amylase 3600 units/100 mg + protease 200 units/100 mg enteric coated granules | has Australian BoSS | lipase | true | Inferred relationship | Some | 1954298724 | |
| lipase 5000 units/100 mg + amylase 3600 units/100 mg + protease 200 units/100 mg enteric coated granules | has intended active ingredient | lipase | true | Inferred relationship | Some | 1954298724 | |
| lipase 5000 units/100 mg + amylase 3600 units/100 mg + protease 200 units/100 mg enteric coated granules | has intended active ingredient | amylase | true | Inferred relationship | Some | 687709330 | |
| lipase 5000 units/100 mg + amylase 3600 units/100 mg + protease 200 units/100 mg enteric coated granules | has Australian BoSS | amylase | true | Inferred relationship | Some | 687709330 | |
| lipase 5000 units/100 mg + amylase 3600 units/100 mg + protease 200 units/100 mg enteric coated granules | has intended active ingredient | protease | true | Inferred relationship | Some | 184028260 | |
| lipase 5000 units/100 mg + amylase 3600 units/100 mg + protease 200 units/100 mg enteric coated granules | has Australian BoSS | protease | true | Inferred relationship | Some | 184028260 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| lipase 5000 units/100 mg + amylase 3600 units/100 mg + protease 200 units/100 mg enteric coated granules, 20 g | has MPUU | True | lipase 5000 units/100 mg + amylase 3600 units/100 mg + protease 200 units/100 mg enteric coated granules | Inferred relationship | Some | 1 |
| Creon Micro enteric coated granules | Is a | True | lipase 5000 units/100 mg + amylase 3600 units/100 mg + protease 200 units/100 mg enteric coated granules | Inferred relationship | Some |
Reference Sets
Medicinal product unit of use reference set
FHIR